Register

Registration

Disclaimer
Terms and Conditions
Questionnaires / Survey
Note : After Answered of Questionnaires / Survey Please Close it.
.

Transchem Ltd . Small Cap

BSE: 500422 | NSE: TRANSCHEM
Pharmaceuticals
Live
20/04/2021 4:00:00 PM
16.50 0.95   (6.11%)
BSE: price shown with 5 mins delayed.
Prev. Close 15.55
Open Price 16.85
Volume Traded 877.00

Fundamentals

Mar'10 Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'19 Mar'20
Ajusted EPS(Rs.)
Net Sales (Rs. Cr.)
Adjusted Net Profit
Book Value/ Share(Rs.)
Cash Flow
Debt to Cash Flow from Operations
RONW
ROCE %
Net Operating Profit Margin %
Net Profit Margin %
Debt / Equity
Dividend Yield %
Mar'10 Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'19 Mar'20
Ajusted EPS(Rs.) 0 0 0 0 0 0.1 0.04 0 0.25 0.33
Net Sales (Rs. Cr.) 0 0 0 0 0 0 0 0 0 0
Adjusted Net Profit -2.01 -1.14 -1.90 -3.74 -0.81 0.13 0.05 -0.42 0.24 0.40
Book Value/ Share(Rs.) 37.99 35.69 32.97 31.89 31.23 31.33 31.37 31.03 31.03 30.04
Cash Flow -0.27 0.00 -0.51 0.29 -0.07 -0.27 0.82 -0.96 16.07 0.04
Debt to Cash Flow from Operations 0.00 0.00 2.46 0.88 0.00 0.00 0.00 0.00 0.00 0.00
RONW 0.00 0.00 0.00 -9.42 -2.07 0.31 0.13 -1.07 0.67 1.10
ROCE % -5.96 -3.28 -4.84 -8.14 -1.79 0.60 0.05 -0.13 1.65 2.10
Net Operating Profit Margin % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit Margin % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt / Equity 0.00 0.03 0.07 0.06 0.02 0.00 0.00 0.00 0.00 0.00
Dividend Yield % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Year on Year Growth Rate (%)

Ajusted EPS Sales Adjusted Net Profit

Latest Financials

Standalone Consolidated
TTM EPS (Rs) 0.98
TTM Sales (Rs. Cr.) 0
BVPS (Rs.) 48.75
Reserves (Rs. Cr.) 47.43
P/BV 0.34
PE 16.84
From the Market
52 Week High / Low (Rs) 24.25/7.31
All Time High / Low (Rs) 450/2.55
Volume Traded 877
Market Cap (Rs. Cr.) 20.2
Equity (Rs. Cr.) 12.24
Face Value (Rs) 10
Industry PE 0

Quarterly Results

Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr) 0.00 0.00 0.00 0.00
Adjusted EPS (Rs) -0.04 0.17 0.25 0.59
Net Profit Margin % 0.00 0.00 0.00 0.00
Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr)
Adjusted EPS (Rs)
Net Profit Margin %

Quarterly Growth Rate (%)

Ajusted EPS Sales Net Profit Margin

Peers Data

Name Current Price(Rs) Market Cap. (Rs. cr.) Net Profit(Rs. cr.) Sales Growth(%)

Technical

Sector

23387.09 280.75   (1.22%)

Index

47705.80 -243.62   (-0.51%)
9 Days Avg
Span A Span B 52 Week TenKan-Sen Kijun-Sen ChiKou-Sen
9 Days Avg

Score

Kindly subscribe to get access

Research Analytical

Kindly subscribe to get access

News

About Company

Transchem (TL) was incorporated as a private limited company on 18 Nov.'76 and converted into a public limited company on 13 Apr.'92. The company is promoted by Chemitex Corporation in association with Rajen Desai,who is the chairman of the company.TL came out with a public issue of 14.22 lac zero-interest FCDs of Rs.120.00 at par aggregating Rs.17.07 crores in Oct.'93, to meet part of the capital cost, and to finance the margin money for working capital, etc, at a project cost of Rs.27.00 crores. The company manufactures bulk drugs in Maharashtra. The company's main products are frusemide, fenbendazole and albendazoie. TL has signed an MoU with Dalsem Reciap Agro Industries, Holland, for their mushroom project -- a 100% EOU -- with buy-back arrangement for a period of 5 years, extendable for another 5 years. The company exports to the US, Canada, Mexico, etc. The company is diversifying into mushroom cultivation. TL is also in the process of finalising collaboration with FTC, Holland, for technological transfer in growing asparagus, strawberries and raspberries.During the year 1999-2000, the mushroom division did well and the sale of Diminazine Aceturate indicate that the company is emerging as a front runner in the product. The company has finalised and commercialised process for Cloursulon and Toldium Phos Sodium.The company has got a contract during the year 2000-01,from an international firm to supply Triclabendazole.